But an excess dose or extra ingredients may mean that you end up with side effects and symptoms beyond those already associated with GLP-1s, including nausea, vomiting, constipation, diarrhea and headaches are all common
This highlights GLP-1 Treatments, Semaglutide or Tirzepatide's potential as a powerful ally in the battle against obesity
Mild to moderate symptoms can usually be treated with simple changes, while more serious or long-lasting diarrhea may need medical treatment
Clinical trials report burping in approximately 1 to 3% of patients
It is a clinical conversation, not a self-serve choice
lot-tracked with COA Form: Lyophilized powder available in 5 mg, 10 mg, 30 mg, and 60 mg vials Areas of Research Interest Retatrutide is investigated in the scientific literature in connection with obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease (MASLD)